Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study

Background: The majority of therapies have generally targeted fasting glucose control, and current mealtime insulin therapies have longer time action profiles than that of endogenously secreted insulin. The primary purpose of this study was to assess both glucose time-in-range (TIR: 70–180 mg/dL) an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Diabetes Technol Ther
Autores principales: Akturk, Halis Kaan, Snell-Bergeon, Janet K., Rewers, Amanda, Klaff, Leslie J., Bode, Bruce W., Peters, Anne L., Bailey, Timothy S., Garg, Satish K.
Formato: Artigo
Lenguaje:Inglês
Publicado: Mary Ann Liebert, Inc., publishers 2018
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6161328/
https://ncbi.nlm.nih.gov/pubmed/30207748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2018.0200
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares